Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
ESMO Open|July 16, 2021
How we treat primary central nervous system lymphomaT Calimeri, S Steffanoni, F Gagliardi, et al.
Current Cancer Drug Targets|December 23, 2009
Challenging the current approaches to multiple myeloma-related bone disease: from bisphosphonates to target therapyP Tassone, P Tagliaferri, M Rossi, et al.
European Journal of Radiology|September 7, 2021
Quantitative muscle mass biomarkers are independent prognosis factors in primary central nervous system lymphoma: The role of L3-skeletal muscle index and temporal muscle thicknessR Leone, G Sferruzza, T Calimeri, et al.
Pageof 1